2023
Clinical predictive value of renalase in post-ERCP pancreatitis
Muniraj T, Desir G, Gorelick F, Guo X, Ciarleglio M, Deng Y, Jamidar P, Farrell J, Aslanian H, Laine L. Clinical predictive value of renalase in post-ERCP pancreatitis. Gastrointestinal Endoscopy 2023, 99: 822-825.e1. PMID: 38103747, DOI: 10.1016/j.gie.2023.12.020.Peer-Reviewed Original ResearchPost-ERCP pancreatitisRenalase levelsPlasma renalase levelsProspective cohort studyPotential clinical roleAcute experimental pancreatitisLongitudinal regression modelsPEP patientsPlasma renalaseCohort studyTertiary hospitalClinical roleExperimental pancreatitisRenalaseAbstractTextERCPPancreatitisFurther studiesAIMSRegression models
2021
Characteristics of Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Sphincter of Oddi Disorders
Coté GA, Nitchie H, Elmunzer BJ, Kwon RS, Willingham FF, Wani S, Mullady D, Chak A, Singh V, Slivka A, Varadarajulu S, Freeman M, Gaddam S, Jamidar P, Tarnasky P, Foster L, Cotton PB. Characteristics of Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Sphincter of Oddi Disorders. Clinical Gastroenterology And Hepatology 2021, 20: e627-e634. PMID: 33716141, PMCID: PMC9053091, DOI: 10.1016/j.cgh.2021.03.008.Peer-Reviewed Original ResearchConceptsEndoscopic retrograde cholangiopancreatographyRetrograde cholangiopancreatographyPatients Undergoing Endoscopic Retrograde CholangiopancreatographyBiliary-type painCharacteristics of patientsRecurrent acute pancreatitisEvaluating PredictorsPostcholecystectomy patientsOddi dysfunctionEndoscopic sphincterotomyBiliary obstructionAcute pancreatitisOddi disordersSham treatmentDysfunction studiesObjective evidenceSphincterPatientsAbsolute numberSphincterotomyCholangiopancreatographyPainPancreatitisDysfunctionObstruction
2020
Comparative effectiveness of pharmacologic and endoscopic interventions for prevention of post-ERCP pancreatitis: a network meta-analysis
Njei B, McCarty TR, Muniraj T, Sharma P, Jamidar PA, Aslanian HR, Varadarajulu S, Navaneethan U. Comparative effectiveness of pharmacologic and endoscopic interventions for prevention of post-ERCP pancreatitis: a network meta-analysis. Endoscopy International Open 2020, 08: e29-e40. PMID: 31921982, PMCID: PMC6949176, DOI: 10.1055/a-1005-6366.Peer-Reviewed Original ResearchRectal non-steroidal anti-inflammatory drugsNon-steroidal anti-inflammatory drugsPost-ERCP pancreatitisPancreatic stent placementHigh-risk patientsStent placementEndoscopic interventionPreventive strategiesPost-endoscopic retrograde cholangiopancreatography pancreatitisCumulative ranking (SUCRA) probabilitiesEffective preventive strategiesAnti-inflammatory drugsWeb of ScienceAggressive hydrationSUCRA probabilitiesCholangiopancreatography pancreatitisCochrane DatabaseProphylactic treatmentPancreatic stentPancreatitisComparative effectivenessSystematic reviewRanking probabilityCombination of LRPatients
2018
Cannabis Use Is Associated With Increased Risk of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Njei B, Sharma P, McCarty TR, Singh M, Haque L, Aslanian HR, Jamidar P, Muniraj T. Cannabis Use Is Associated With Increased Risk of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas 2018, 47: 1142-1149. PMID: 30134357, DOI: 10.1097/mpa.0000000000001143.Peer-Reviewed Original ResearchConceptsPost-endoscopic retrograde cholangiopancreatography pancreatitisIncidence risk ratioCholangiopancreatography pancreatitisCannabis useRisk of PEPEndoscopic retrograde cholangiopancreatography pancreatitisUS Nationwide Inpatient SampleRate of PEPShorter hospital stayNationwide Inpatient SampleNinth Edition codesImpact of cannabisPoisson regression modelsHospital deathHospital stayIndependent predictorsEdition codesRisk ratioInpatient SampleInternational ClassificationMultivariate analysisPancreatitisPatientsCannabisSignificant increase
2017
Comparative Effectiveness of Pharmacologic and Endoscopic Interventions for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: A Network Meta-Analysis
Njei B, McCarty T, Sharma P, Muniraj T, Jamidar P, Aslanian H, Navaneethan U. Comparative Effectiveness of Pharmacologic and Endoscopic Interventions for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: A Network Meta-Analysis. The American Journal Of Gastroenterology 2017, 112: s449-s450. DOI: 10.14309/00000434-201710001-00807.Peer-Reviewed Original Research
2015
Endoscopic Retrograde Cholangiopancreatography–Related Adverse Events General Overview
Rustagi T, Jamidar PA. Endoscopic Retrograde Cholangiopancreatography–Related Adverse Events General Overview. Gastrointestinal Endoscopy Clinics Of North America 2015, 25: 97-106. PMID: 25442961, DOI: 10.1016/j.giec.2014.09.005.Peer-Reviewed Original ResearchConceptsEndoscopic retrograde cholangiopancreatographyAdverse eventsRetrograde cholangiopancreatographyERCP-related adverse eventsProcedure-related risk factorsOverall adverse event rateAdverse event ratesManagement of patientsPost-ERCP pancreatitisRoutine endoscopic proceduresRisk factorsPancreaticobiliary diseasesEndoscopic proceduresEvent ratesCholangiopancreatographyMonumental advancesInherent risksHigher inherent riskBleedingPancreatitisSedationPatientsInfectionDiseaseDiagnosis
2014
Chronic pancreatitis, a comprehensive review and update. Part I: Epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features
Muniraj T, Aslanian HR, Farrell J, Jamidar PA. Chronic pancreatitis, a comprehensive review and update. Part I: Epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features. Disease-a-Month 2014, 60: 530-550. PMID: 25510320, DOI: 10.1016/j.disamonth.2014.11.002.Peer-Reviewed Original Research
2007
Endoscopic therapy for the treatment of pain in chronic pancreatitis: a success story in tropical pancreatitis
Siddiqui UD, Jamidar PA. Endoscopic therapy for the treatment of pain in chronic pancreatitis: a success story in tropical pancreatitis. Gastrointestinal Endoscopy 2007, 66: 76-78. PMID: 17591477, DOI: 10.1016/j.gie.2007.05.005.Peer-Reviewed Original Research
2005
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis
Mosler P, Sherman S, Marks J, Watkins JL, Geenen JE, Jamidar P, Fogel EL, Lazzell-Pannell L, Temkit M, Tarnasky P, Block KP, Frakes JT, Aziz AA, Malik P, Nickl N, Slivka A, Goff J, Lehman GA. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointestinal Endoscopy 2005, 62: 245-250. PMID: 16046988, DOI: 10.1016/s0016-5107(05)01572-5.Peer-Reviewed Original ResearchConceptsPost-ERCP pancreatitisOral allopurinolAllopurinol groupControl groupOxygen-derived free radical productionPlacebo 4 hoursProcedure risk factorsCommon major complicationSeverity of pancreatitisFree radical productionProphylactic allopurinolPatient demographicsMajor complicationsOverall incidencePostprocedure pancreatitisPharmacologic agentsRisk factorsPancreatitisPatientsStandardized criteriaAllopurinolERCPSeveritySignificant differencesIncidence
1996
Pancreatitis complicating endoscopic biliary sphincterotomy (ES): A prospective multivariate analysis of risk factors including pancreatic sphincter hypertension (PSH)
Freeman M, Mallery S, Sherman S, Jamidar P, Silverman W, Ryan M, Cunningham J, Haber G, Herman M, Nelson D. Pancreatitis complicating endoscopic biliary sphincterotomy (ES): A prospective multivariate analysis of risk factors including pancreatic sphincter hypertension (PSH). Gastrointestinal Endoscopy 1996, 43: 381. DOI: 10.1016/s0016-5107(96)80361-0.Peer-Reviewed Original Research
1994
Survey of informed consent for endoscopic retrograde cholangiopancreatography
Newton J, Hawes R, Jamidar P, Harig J, Lehman G. Survey of informed consent for endoscopic retrograde cholangiopancreatography. Digestive Diseases And Sciences 1994, 39: 1714-1718. PMID: 8050323, DOI: 10.1007/bf02087782.Peer-Reviewed Original ResearchConceptsTherapeutic ERCPProlonged hospital stayEndoscopic retrograde cholangiopancreatographyHealth care team membersGastrointestinal endoscopic proceduresPrivate practice physiciansHospital stayRetrograde cholangiopancreatographyInformed consent processPractice physiciansEndoscopic proceduresAdequate informationPatientsPhysiciansConsent processVariation of opinionERCPConsentPotential needCurrent opinionPotential riskCholangiopancreatographyPancreatitisStaySurgery
1993
Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients
Smithline A, Silverman W, Rogers D, Nisi R, Wiersema M, Jamidar P, Hawes R, Lehman G. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointestinal Endoscopy 1993, 39: 652-657. PMID: 8224687, DOI: 10.1016/s0016-5107(93)70217-5.Peer-Reviewed Original ResearchConceptsHigh-risk patientsMain pancreatic ductSmaller common bile duct diameterCommon bile duct diameterBile duct diameterStent groupEndoscopic sphincterotomyPancreatic ductDuct diameterIncidence of pancreatitisIndependent risk factorPre-cut sphincterotomyOddi dysfunctionProphylactic stentingHospital daysCommon complicationPapillary edemaSevere pancreatitisBiliary sphincterotomyStent placementRisk factorsProspective fashionSphincterotomyPancreatitisPatients